5 Best Rated Penny Stocks to Buy According to Analysts

4. Atara Biotherapeutics Inc. (NASDAQ:ATRA)

Analyst Price Target: $20.98

Upside Potential: 903.83%

Atara Biotherapeutics Inc. (NASDAQ:ATRA) is one of the best rated penny stocks to buy. Atara Biotherapeutics Inc. (NASDAQ:ATRA) currently has a “Strong Buy” rating from Wall Street analysts.  Analysts and investors are awaiting a potential upcoming growth catalyst for the stock in October 2023 when Atara Biotherapeutics Inc. (NASDAQ:ATRA) is expected to post the results of its Phase 2 study on its treatment of progressive multiple sclerosis.

Insider Monkey’s database of 943 hedge funds shows that 14 hedge funds had stakes in Atara Biotherapeutics Inc. (NASDAQ:ATRA) as of the end of the first quarter of 2023. The biggest stakeholder of Atara Biotherapeutics Inc. (NASDAQ:ATRA) was Lee Ainslie’s Maverick Capital which owns an $18.2 million stake in the company.